MX2022016444A - Composiciones veterinarias para la prevencion y/o tratamiento de la leishmaniosis. - Google Patents
Composiciones veterinarias para la prevencion y/o tratamiento de la leishmaniosis.Info
- Publication number
- MX2022016444A MX2022016444A MX2022016444A MX2022016444A MX2022016444A MX 2022016444 A MX2022016444 A MX 2022016444A MX 2022016444 A MX2022016444 A MX 2022016444A MX 2022016444 A MX2022016444 A MX 2022016444A MX 2022016444 A MX2022016444 A MX 2022016444A
- Authority
- MX
- Mexico
- Prior art keywords
- leishmaniosis
- treating
- preventing
- veterinary compositions
- veterinary
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- FIHJKUPKCHIPAT-AHIGJZGOSA-N artesunate Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2O[C@@H](OC(=O)CCC(O)=O)[C@@H]4C FIHJKUPKCHIPAT-AHIGJZGOSA-N 0.000 abstract 1
- 229960004991 artesunate Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
Abstract
La presente invención se refiere a una composición veterinaria que comprende artesunato o una sal del mismo, y un excipiente farmacéuticamente aceptable, para el uso para prevenir y/o tratar leishmaniosis en un perro.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20305791 | 2020-07-09 | ||
| PCT/EP2021/069120 WO2022008708A1 (en) | 2020-07-09 | 2021-07-09 | Veterinary compositions for preventing and/or treating leishmaniosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022016444A true MX2022016444A (es) | 2023-02-01 |
Family
ID=71944048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022016444A MX2022016444A (es) | 2020-07-09 | 2021-07-09 | Composiciones veterinarias para la prevencion y/o tratamiento de la leishmaniosis. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4178570B1 (es) |
| KR (1) | KR20230038140A (es) |
| CN (1) | CN115803021B (es) |
| BR (1) | BR112022026791A2 (es) |
| CL (1) | CL2022003691A1 (es) |
| ES (1) | ES2988643T3 (es) |
| IL (1) | IL299714A (es) |
| MX (1) | MX2022016444A (es) |
| WO (1) | WO2022008708A1 (es) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2884715B1 (fr) * | 2005-04-20 | 2007-06-15 | Sanofi Aventis Sa | Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme |
| BRPI1002067A8 (pt) * | 2010-05-11 | 2017-10-31 | Coop Dos Produtores De Cogumelos Da Regiao Metropolitana De Belohorizonte Minasfungi Do Brasil | Formulação leishmanicida e seu uso |
-
2021
- 2021-07-09 MX MX2022016444A patent/MX2022016444A/es unknown
- 2021-07-09 WO PCT/EP2021/069120 patent/WO2022008708A1/en not_active Ceased
- 2021-07-09 KR KR1020227044098A patent/KR20230038140A/ko active Pending
- 2021-07-09 BR BR112022026791A patent/BR112022026791A2/pt unknown
- 2021-07-09 IL IL299714A patent/IL299714A/en unknown
- 2021-07-09 EP EP21740528.1A patent/EP4178570B1/en active Active
- 2021-07-09 ES ES21740528T patent/ES2988643T3/es active Active
- 2021-07-09 CN CN202180039701.4A patent/CN115803021B/zh active Active
-
2022
- 2022-12-21 CL CL2022003691A patent/CL2022003691A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN115803021B (zh) | 2025-04-18 |
| CN115803021A (zh) | 2023-03-14 |
| WO2022008708A1 (en) | 2022-01-13 |
| KR20230038140A (ko) | 2023-03-17 |
| CL2022003691A1 (es) | 2023-06-09 |
| EP4178570B1 (en) | 2024-08-28 |
| BR112022026791A2 (pt) | 2023-05-02 |
| EP4178570C0 (en) | 2024-08-28 |
| IL299714A (en) | 2023-03-01 |
| ES2988643T3 (es) | 2024-11-21 |
| EP4178570A1 (en) | 2023-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20237568B (en) | 2-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitors | |
| FI3618875T3 (fi) | Raf-inhibiittoria ja trametinibia käsittävä yhdistelmähoito | |
| TN2017000374A1 (en) | TGF-β INHIBITORS | |
| MY206733A (en) | Compounds and compositions for treating conditions associated with nlrp activity | |
| TW201613887A (en) | Antiproliferative compounds and methods of use thereof | |
| CY1112478T1 (el) | Ενωσεις κιναζολινονης ως αντικαρκινικοι παραγοντες | |
| PT2383271E (pt) | Aminoquinolonas como inibidores de gsk-3 | |
| GEP201606555B (en) | Compounds and compositions for modulating egfr activity | |
| NZ754962A (en) | Compositions and methods for treating, ameliorating and preventing h. pylori infections | |
| TW200718689A (en) | 2-Amino-quinazolin-5-ones | |
| MX2010002667A (es) | Cianoaminoquinolonas y tetrazoloaminoquinolonas como inhibidores de gsk-3. | |
| PH12022550448A1 (en) | Niclosamide delayed-release composition and antiviral use thereof | |
| MY197464A (en) | Aza-indazole compounds for use in tendon and/or ligament injuries | |
| PH12021551157A1 (en) | Ketamine pamoate and use thereof | |
| MX2022007285A (es) | Compuestos, polimeros, dispositivos y usos de los mismos. | |
| ZA202210640B (en) | Deuterated oxophenylarsine compound and use thereof | |
| MX2021011289A (es) | Composiciones que comprenden moduladores de isoenzima m2 muscular de piruvato cinasa pkm2 y metodos de tratamiento que usan las mismas. | |
| MX2021005944A (es) | Inhibidores de rip1. | |
| PH12020500510A1 (en) | Prophylactic and/or therapeutic agent for diseases involving ido expression | |
| MX2022016444A (es) | Composiciones veterinarias para la prevencion y/o tratamiento de la leishmaniosis. | |
| PH12019500327A1 (en) | Indazole compounds for use in tendon and/or ligament injuries | |
| MX2022006179A (es) | Derivados macrociclicos de indol como inhibidores de mcl-1. | |
| MX2019001771A (es) | Composición farmacéutica sólida que comprende el sofosbuvir amorfo. | |
| PH12021550093A1 (en) | Compounds for use in the treatment of fascioliasis | |
| MX2022000308A (es) | Formulacion de nanoparticulas de inhibidor de bcl-2. |